Single-use Technologies for Biopharmaceuticals Market By Type (Single-use Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess Containers, and Others), By Application (Contract Manufacturing Organizations and Biopharmaceutical Manufacturers), Industry Trends, Estimation & Forecast, 2023-2030

Market Definition

The biopharmaceutical industry is rapidly adopting Single-use technologies for bioprocessing to reduce the risk of cross-contamination. Single-use bioprocessing equipment is designed to be used once. Single-use bioprocessing equipment is primarily composed of plastic components that have been sealed and sterilized using gamma irradiation. Single-use technology in the biopharmaceutical industry include bioreactors, membrane absorbers, media bags, mixers, bioprocess containers, and others.

The Single-use Technologies for Biopharmaceuticals market was valued at 4.8 billion US$ in 2022 and is projected to reach 12.3 billion US$ by 2030, at a CAGR of 12.5% during the forecast period.

Market Dynamics

Increasing investments in Single-use technologies for biopharmaceuticals is anticipated to boost the global Single-use technologies for the biopharmaceuticals market. The biopharmaceutical industry is rapidly adopting Single-use technologies for bioprocessing in order to reduce the risk of cross-contamination. The biopharmaceutical companies are investing in Single-use technologies to increase their R&D activities, development capacity, commercialization of new products, and expanding the geographical presence. For instance, Thermo Fisher Scientific Inc. has invested more than $50 million in bioproduction to provide additional capacity for manufacturing Single-use bioprocess container systems. Thermo Fisher’s Single-use technologies are used for sterile liquid-handling applications in the biopharmaceutical industry to ensure quality in the production of biologic drugs and increase productivity. Further, reduce energy, time, and water consumption is a key driving factor of the market. The transition from conventional equipment to the Single-use system results in less energy demand and water consumption. As per the researchers, the biopharmaceutical manufacturing plants which has adopted Single-use technologies experienced a 46% decline in total water consumption and energy consumption as compared to a stainless-steel reactor. Single-use technologies also eliminate the CIP and SIP steps, which leads to at least eight months of shorter project duration. The reduction of time and water consumption has also reduced the related cost. However, the risk associated with extractables and leachables, and product failure might hamper the market growth. Moreover, technological advancement and awareness of Single-use technologies for biopharmaceuticals would provide lucrative opportunities for the market in the coming years.

Market Segmentation

The global Single-use technologies for biopharmaceuticals market is mainly classified based on type and application. Type is further segmented into Single-use Bioreactors, Membrane Adsorbers, Media Bags, Bioprocess Containers, and Others. By application, the market is divided into Contract Manufacturing Organizations and Biopharmaceutical Manufacturers.

The Single-use bioreactor was dominating the global Single-use technologies for biopharmaceuticals market in 2019, and it is expected to grow in the coming years, owing to the increasing investment to expand the capacity for manufacturing Single-use bioprocess container (BPC) and commercialization of new Single-use bioreactors. For instance, ABEC has introduced a Single-use bioreactor system with a working volume of 6,000 L, which is three times of industry’s standard upper limit. Many vendors offer bioreactors of 2,000 L as their upper limit, which leads to either run several systems in unison or opt for stainless-steel tanks. The company has also introduced the 4,000 L Single-use bioreactor system, with two times that of industry’s standard upper limit.

Regional Analysis

Based on geography, the global Single-use technologies for biopharmaceuticals market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the global Single-use technologies for biopharmaceuticals market in 2019, and it is expected to grow in the coming years. Technological advancement and awareness about Single-use technologies for biopharmaceuticals and commercialization of regulatory approved Single-use technologies for biopharmaceuticals are some of the factors driving the North American Single-use technologies for biopharmaceuticals market. For instance, MilliporeSigma has introduced three Single-use bioprocessing products. The product includes Pellicon capsule with Ultracel membrane, Millipak final fill filter, and Mobius Power MIX 2500-liter and 3000-liter. Pellicon Capsule with Ultracel Membrane is a Single-use tangential flow filtration device that advances flexible manufacturing. Millipak Final Fill Filter is used for high-value, small-volume processing. Mobius Power MIX 2,500-Litre and 3,000-Litre are large-scale Single-use mixers.

Competitive landscape

Key players operating in the Single-use technologies for biopharmaceuticals industry include Merck KGaA, Cytiva Lifesciences, Pall Corp, Sartorius Stedim Biotech, Thermo Fisher, Eppendorf, Parker Hannifin, Applikon Biotechnology, Corning Inc, and Repligen Corp.

The commercialization of new Single-use biopharmaceutical products, the increasing investment to expand the additional capacity for manufacturing Single-use bioprocess container (BPC) systems and the collaboration between companies to distribute the Single-use biopharmaceutical products at a global scale are some of the strategies adopted by major players. For instance, on March 13, 2019, Pall Corporation has signed a collaboration agreement with ARTeSYN Biosolutions. Based on the agreement, the Pall Biotech line of business will immediately distribute ARTeSYN’s standard hardware and liner components off the shelf. ARTeSYN valves offer unmatched biopharmaceutical fluid flow control, with a compact, durable Single-use design for simple installation and maintenance.

Single-use Technologies for Biopharmaceuticals Market Key Segments

By Type
• Single-use Bioreactors
• Membrane Adsorbers
• Media Bags
• Bioprocess Containers
• Others

By Application
• Contract Manufacturing Organizations
• Biopharmaceutical Manufacturers

Key Global Single-use Technologies for Biopharmaceuticals Industry Players

• Merck KGaA
• Cytiva Lifesciences
• Pall Corp
• Sartorius Stedim Biotech
• Thermo Fisher
• Eppendorf
• Parker Hannifin
• Applikon Biotechnology
• Corning Inc
• Repligen Corp.

Table of Content

1. Market Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. Market Scope

2. Research Methodology
2.1. Primary Research
2.2. Research Methodology
2.3. Assumptions & Exclusions
2.4. Secondary data sources

3. Single-use Technologies for Biopharmaceuticals Market Overview
3.1. Report Segmentation & Scope
3.2. Key Market Trend
3.3. Drivers
3.3.1. Increasing Investments in Single-use Technologies for Biopharmaceuticals
3.3.2. Reduce Energy, Time and Water Consumption
3.4. Restraints
3.4.1. Risk Associated with Extractables and Leachables, and Product Failure
3.5. Opportunity
3.5.1. Technological advancement and Awareness on Single-use Technologies for Biopharmaceuticals
3.6. Porter’s Five Forces Analysis
3.6.1. Porter’s Five Forces Analysis
3.7. Market Share Analysis

4. Type Overview
4.1. Introduction
4.1.1. Market Size & Forecast
4.2. Single-use Bioreactors
4.2.1. Market Size & Forecast
4.3. Membrane Adsorbers
4.3.1. Market Size & Forecast
4.4. Media Bags
4.4.1. Market Size & Forecast
4.5. Bioprocess Containers
4.5.1. Market Size & Forecast
4.6. Others
4.6.1. Market Size & Forecast

5. Application Overview
5.1. Introduction
5.1.1. Market Size & Forecast
5.2. Contract Manufacturing Organizations
5.2.1. Market Size & Forecast
5.3. Biopharmaceutical Manufacturers
5.3.1. Market Size & Forecast

6. Single-use Technologies for Biopharmaceuticals Market Regional Overview
6.1. Introduction
6.1.1. Market Size & Forecast
6.2. North America Single-use Technologies for Biopharmaceuticals Market
6.2.1. North America Market Size & Forecast, By Country
6.2.2. North America Market Size & Forecast, By Type
6.2.3. North America Market Size & Forecast, By Application
6.2.4. U.S.
6.2.4.1. Market Size and Forecast
6.2.5. Canada
6.2.5.1. Market Size and Forecast
6.2.6. Mexico
6.2.6.1. Market Size and Forecast
6.3. Europe Single-use Technologies for Biopharmaceuticals Market
6.3.1. Europe Market Size & Forecast, By Country
6.3.2. Europe Market Size & Forecast, By Type
6.3.3. Europe Market Size & Forecast, By Application
6.3.4. Germany
6.3.4.1. Market Size and Forecast
6.3.5. France
6.3.5.1. Market Size and Forecast
6.3.6. UK
6.3.6.1. Market Size and Forecast
6.3.7. Italy
6.3.7.1. Market Size and Forecast
6.3.8. Spain
6.3.8.1. Market Size and Forecast
6.3.9. Rest of Europe
6.3.9.1. Market Size and Forecast
6.4. Asia-Pacific Single-use Technologies for Biopharmaceuticals Market
6.4.1. Asia-Pacific Market Size & Forecast, By Country
6.4.2. Asia-Pacific Market Size & Forecast, By Type
6.4.3. Asia-Pacific Market Size & Forecast, By Application
6.4.4. Japan
6.4.4.1. Market Size and Forecast
6.4.5. China
6.4.5.1. Market Size and Forecast
6.4.6. Australia
6.4.6.1. Market Size and Forecast
6.4.7. India
6.4.7.1. Market Size and Forecast
6.4.8. South Korea
6.4.8.1. Market Size and Forecast
6.4.9. Rest of Asia-Pacific
6.4.9.1. Market Size and Forecast
6.5. South America Single-use Technologies for Biopharmaceuticals Market
6.5.1. South America Market Size & Forecast, By Country
6.5.2. South America Market Size & Forecast, By Type
6.5.3. South America Market Size & Forecast, By Application
6.5.4. Brazil
6.5.4.1. Market Size and Forecast
6.5.5. Argentina
6.5.5.1. Market Size and Forecast
6.5.6. Rest of South America
6.5.6.1. Market Size and Forecast
6.6. Middle East & Africa Single-use Technologies for Biopharmaceuticals Market
6.6.1. Middle East & Africa Market Size & Forecast, By Country
6.6.2. Middle East & Africa Market Size & Forecast, By Type
6.6.3. Middle East & Africa Market Size & Forecast, By Application
6.6.4. GCC Countries
6.6.4.1. Market Size and Forecast
6.6.5. Egypt
6.6.5.1. Market Size and Forecast
6.6.6. South Africa
6.6.6.1. Market Size and Forecast
6.6.7. Rest of Middle East & Africa
6.6.7.1. Market Size and Forecast

7. Company Profile
7.1. Merck KGaA
7.1.1. Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2. Merck KGaA Product Category, Application, and Specification
7.1.3. Merck KGaA Financial Performance (2016-2018)
7.1.4. Main Business/Business Overview
7.2. Cytiva Lifesciences
7.3. Pall Corp
7.4. Sartorius Stedim Biotech
7.5. Thermo Fisher
7.6. Eppendorf
7.7. Parker Hannifin
7.8. Applikon Biotechnology
7.9. Corning Inc
7.10. Repligen Corp.